Rethinking Lyme Disease Testing: A New Approach to Early Detection
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
New research marks a promising step toward rethinking how we identify and manage Lyme disease and related infections in the clinical lab
When it comes to cyberattacks, the threat is “when,” not “if”—and labs must be prepared to mitigate, contain, and recover from breaches
The grants, which include $3 million from the NIH and $1 million from the NSF, will help the company develop point-of-care tests
Exploring the opportunities, challenges, and current research in lab-based testing for mental health disorders
Laboratorian and workplace wellness expert discusses mental health challenges in the lab—and how to foster safety and support
What lab tests currently inform mental health care—and how might the testing landscape change as our understanding and technologies evolve?
Workplace bullying is a serious concern in the clinical lab. How can it be addressed?
Andreas Jeromin, PhD, chief scientific officer at ALZPath, discusses the current landscape of blood-based AD tests and their future.
Alison Green, PhD, head of laboratory sciences at Scottish Brain Sciences, discusses recent developments in AD blood tests
A new capillary blood collection system, the BD MiniDraw™, can improve the testing experience for both labs and patients
Examining what led to record low BB/TM ABPath certification examination pass rates in 2022